Michael G. Darcy

1.8k total citations
13 papers, 524 citations indexed

About

Michael G. Darcy is a scholar working on Organic Chemistry, Epidemiology and Infectious Diseases. According to data from OpenAlex, Michael G. Darcy has authored 13 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Michael G. Darcy's work include Chemokine receptors and signaling (3 papers), Hepatitis C virus research (3 papers) and HIV/AIDS drug development and treatment (3 papers). Michael G. Darcy is often cited by papers focused on Chemokine receptors and signaling (3 papers), Hepatitis C virus research (3 papers) and HIV/AIDS drug development and treatment (3 papers). Michael G. Darcy collaborates with scholars based in United States, United Kingdom and Slovakia. Michael G. Darcy's co-authors include Walter W. Zajac, Thomas R. Walters, Dashyant Dhanak, Richard M. Keenan, John R. White, Henry M. Sarau, Katherine L. Widdowson, Anthony J. Jurewicz, Victor K. Johnston and Robert T. Sarisky and has published in prestigious journals such as Journal of Biological Chemistry, Green Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Michael G. Darcy

13 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael G. Darcy United States 12 222 135 82 69 65 13 524
Toshihiko Nagase Japan 13 167 0.8× 207 1.5× 30 0.4× 14 0.2× 39 0.6× 30 459
Matthew Bennett United States 10 94 0.4× 327 2.4× 26 0.3× 6 0.1× 45 0.7× 12 541
Hongying Yun China 14 395 1.8× 123 0.9× 31 0.4× 34 0.5× 13 0.2× 20 642
G. Lüben Germany 14 65 0.3× 266 2.0× 27 0.3× 14 0.2× 88 1.4× 27 627
Liu Wang China 15 145 0.7× 199 1.5× 17 0.2× 24 0.3× 26 0.4× 56 696
Youichi Nishikawa Japan 14 241 1.1× 168 1.2× 11 0.1× 9 0.1× 64 1.0× 41 628
Thomas Gossas Sweden 14 183 0.8× 332 2.5× 70 0.9× 28 0.4× 19 0.3× 21 583
Shi‐Shan Mao United States 12 104 0.5× 211 1.6× 67 0.8× 5 0.1× 26 0.4× 18 617
Andrew M. Mason United Kingdom 13 278 1.3× 185 1.4× 7 0.1× 23 0.3× 43 0.7× 19 534
Timothy A. Stammers Canada 13 220 1.0× 117 0.9× 116 1.4× 3 0.0× 34 0.5× 21 462

Countries citing papers authored by Michael G. Darcy

Since Specialization
Citations

This map shows the geographic impact of Michael G. Darcy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Darcy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Darcy more than expected).

Fields of papers citing papers by Michael G. Darcy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Darcy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Darcy. The network helps show where Michael G. Darcy may publish in the future.

Co-authorship network of co-authors of Michael G. Darcy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Darcy. A scholar is included among the top collaborators of Michael G. Darcy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Darcy. Michael G. Darcy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Adams, Joseph P., Catherine M. Alder, Ian P. Andrews, et al.. (2013). Development of GSK's reagent guides – embedding sustainability into reagent selection. Green Chemistry. 15(6). 1542–1542. 84 indexed citations
2.
Shaw, Antony N., Rosanna Tedesco, Ramesh Bambal, et al.. (2009). Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 19(15). 4350–4353. 37 indexed citations
3.
Tedesco, Rosanna, Deping Chai, Michael G. Darcy, et al.. (2009). Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4354–4358. 19 indexed citations
4.
Gu, Baohua, Victor K. Johnston, Lester L. Gutshall, et al.. (2003). Arresting Initiation of Hepatitis C Virus RNA Synthesis Using Heterocyclic Derivatives. Journal of Biological Chemistry. 278(19). 16602–16607. 55 indexed citations
5.
Dhanak, Dashyant, Michael G. Darcy, Richard M. Keenan, et al.. (2001). Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2. Bioorganic & Medicinal Chemistry Letters. 11(11). 1445–1450. 23 indexed citations
6.
Dhanak, Dashyant, Michael G. Darcy, Anthony J. Jurewicz, et al.. (2001). Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1. Bioorganic & Medicinal Chemistry Letters. 11(11). 1441–1444. 16 indexed citations
7.
Dhanak, Dashyant, George Burton, Michael G. Darcy, et al.. (2000). Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease. Bioorganic & Medicinal Chemistry Letters. 10(20). 2279–2282. 10 indexed citations
8.
White, John R., Judithann M. Lee, Anthony J. Jurewicz, et al.. (2000). Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration. Journal of Biological Chemistry. 275(47). 36626–36631. 98 indexed citations
9.
Dhanak, Dashyant, Richard M. Keenan, George Burton, et al.. (1998). Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease. Bioorganic & Medicinal Chemistry Letters. 8(24). 3677–3682. 42 indexed citations
10.
Thompson, Scott K., James S. Frazee, Michael G. Darcy, et al.. (1994). Synthesis and antiviral activity of a novel class of HIV-1 protease inhibitors containing a heterocyclic P1′-P2′ amide bond isostere. Bioorganic & Medicinal Chemistry Letters. 4(20). 2441–2446. 38 indexed citations
11.
Zajac, Walter W., et al.. (1989). Oxidation of primary aliphatic amines with sodium perborate. Tetrahedron Letters. 30(47). 6495–6496. 17 indexed citations
12.
Zajac, Walter W., Thomas R. Walters, & Michael G. Darcy. (1988). Oxidation of amines with 2-sulfonyloxaziridines (Davis' reagents). The Journal of Organic Chemistry. 53(25). 5856–5860. 74 indexed citations
13.
Darcy, Michael G., David E. Rogers, & Peter J. Derrick. (1978). Design of mass spectrometers for field ionization and field desorption. International Journal of Mass Spectrometry and Ion Physics. 27(4). 335–347. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026